Search
for
Sort by
Research 31–60 of 655
- What causes hidradenitis suppurativa ?—15 years after
- Autoimmunity and autoimmune co-morbidities in psoriasis
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata
- The Role of T‐Helper 17 Cells and Regulatory T Cells in Acute Diffuse and Total Alopecia: The Increased Function of Regulatory T Cells May Explain the Favorable Prognosis
- Epidermal Notch1 recruits innate lymphoid cells to orchestrate normal skin repair
- <i>Malassezia</i> and the Asian menopausal skin
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Tregs: Where We Are and What Comes Next?
- Impaired Notch‐MKP‐1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia?
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- An Update on Medical Treatment Options for Hidradenitis Suppurativa
- Update on hidradenitis suppurativa: connecting the tracts
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- New developments in the molecular treatment of ichthyosis: review of the literature
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS